Comment on NIH authorizes first human trial of CRISPR gene-editing technique

NIH authorizes first human trial of CRISPR gene-editing technique

Forget GMO. Get ready for GMH. CRISPR, the genome-editing technology that has taken biomedical science by storm, is finally nearing human trials. On 21 June, an advisory committee at the US National Institutes of Health (NIH) approved a proposal to use CRISPR–Cas9 to help augment cancer therapies that rely on enlisting a patient’s T cells, a type of immune cell. Where some gene modification techniques have involved the brute-force insertion of genetic material (including shooting at cells with an air pistol), CRISPR is a much more exacting technique that offers multiple approaches to carefully editing genes, including human genes. What CRISPR offers, and biologists desire, is specificity: the ability to target and study particular DNA sequences in the vast expanse of a genome.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Politics News